End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.33 CNY | +4.24% | +2.61% | +20.05% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The group's high margin levels account for strong profits.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- With an expected P/E ratio at 67.38 and 46.41 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.05% | 1.9B | - | ||
-28.30% | 16.25B | A | ||
-39.00% | 3.01B | C+ | ||
-9.59% | 1.51B | - | ||
+39.34% | 1.43B | B+ | ||
-18.07% | 944M | - | ||
-27.78% | 827M | - | C- | |
+3.39% | 819M | - | ||
-22.44% | 650M | B+ | ||
+28.07% | 618M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300049 Stock
- Ratings Inner Mongolia Furui Medical Science Co., Ltd.